Deciphera Pharmaceuticals Inc (DCPH)
25.38
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
25.37
-0.01
(-0.04%)
After-Hours: 20:00
Deciphera Pharmaceuticals Market Cap: 2.051B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 03, 2024 | 2.051B |
May 02, 2024 | 2.051B |
May 01, 2024 | 2.049B |
April 30, 2024 | 2.042B |
April 29, 2024 | 2.043B |
April 26, 2024 | 1.184B |
April 25, 2024 | 1.146B |
April 24, 2024 | 1.181B |
April 23, 2024 | 1.185B |
April 22, 2024 | 1.178B |
April 19, 2024 | 1.185B |
April 18, 2024 | 1.150B |
April 17, 2024 | 1.189B |
April 16, 2024 | 1.199B |
April 15, 2024 | 1.204B |
April 12, 2024 | 1.216B |
April 11, 2024 | 1.254B |
April 10, 2024 | 1.261B |
April 09, 2024 | 1.264B |
April 08, 2024 | 1.213B |
April 05, 2024 | 1.239B |
April 04, 2024 | 1.223B |
April 03, 2024 | 1.235B |
April 02, 2024 | 1.227B |
April 01, 2024 | 1.273B |
Date | Value |
---|---|
March 28, 2024 | 1.271B |
March 27, 2024 | 1.227B |
March 26, 2024 | 1.197B |
March 25, 2024 | 1.236B |
March 22, 2024 | 1.231B |
March 21, 2024 | 1.252B |
March 20, 2024 | 1.273B |
March 19, 2024 | 1.210B |
March 18, 2024 | 1.200B |
March 15, 2024 | 1.260B |
March 14, 2024 | 1.286B |
March 13, 2024 | 1.291B |
March 12, 2024 | 1.300B |
March 11, 2024 | 1.336B |
March 08, 2024 | 1.369B |
March 07, 2024 | 1.368B |
March 06, 2024 | 1.368B |
March 05, 2024 | 1.357B |
March 04, 2024 | 1.342B |
March 01, 2024 | 1.403B |
February 29, 2024 | 1.349B |
February 28, 2024 | 1.358B |
February 27, 2024 | 1.366B |
February 26, 2024 | 1.328B |
February 23, 2024 | 1.298B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
402.26M
Minimum
Mar 07 2022
3.768B
Maximum
Nov 16 2020
1.694B
Average
1.266B
Median
Feb 16 2024
Market Cap Benchmarks
Bristol-Myers Squibb Co | 89.17B |
Dynavax Technologies Corp | 1.533B |
Gilead Sciences Inc | 80.78B |
Esperion Therapeutics Inc | 384.91M |
SINTX Technologies Inc | 5.754M |
Market Cap Related Metrics
PS Ratio | 13.21 |
Price to Book Value | 5.844 |
Price | 25.38 |
Earnings Yield | -9.02% |